Zobrazeno 1 - 10
of 30
pro vyhledávání: '"J C, Grutters"'
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Idiopathic pulmonary fibrosis (IPF) often has significant diagnostic delay. At present it is not well-known what factors associate with time to diagnosis and if this is associated with survival after the diagnosis. There has also
Externí odkaz:
https://doaj.org/article/b9e5c742afbd4ca391695cf006a5754c
Autor:
M. C. Schimmelpennink, D. B. Meek, A. D. M. Vorselaars, L. C. M. Langezaal, C. H. M. van Moorsel, J. J. van der Vis, M. Veltkamp, J. C. Grutters
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in patients with progressive fibrosing interstitial lung diseases (PF-ILD), including a few wit
Externí odkaz:
https://doaj.org/article/c46a96ad0a0948658b14e8264ff2d4c3
Autor:
H. Mathijssen, T. W. H. Tjoeng, R. G. M. Keijsers, A. L. M. Bakker, F. Akdim, H. W. van Es, F. T. van Beek, M. V. Veltkamp, J. C. Grutters, M. C. Post
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Background Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain,
Externí odkaz:
https://doaj.org/article/8b6a618114a74df9b872da7b44bf98a2
Autor:
C. C. Moor, R. L. M. Mostard, J. C. Grutters, P. Bresser, J. G. J. V. Aerts, C. D. Dirksen, M. L. Kimman, M. S. Wijsenbeek
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background Two antifibrotic drugs, nintedanib and pirfenidone, are available for treatment of idiopathic pulmonary fibrosis (IPF). Although efficacy and adverse events have been well studied, little is known about patient experiences with th
Externí odkaz:
https://doaj.org/article/10f6f4eeb9b8475691adf1a7cc793f57
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 50, 7, pp. 1929-1939
Adams, H, van de Garde, E M W, Vugts, D J, Grutters, J C, Oyen, W J G & Keijsers, R G 2023, ' [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis : a phase 2 trial ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 7, pp. 1929-1939 . https://doi.org/10.1007/s00259-023-06143-1
European Journal of Nuclear Medicine and Molecular Imaging, 50(7), 1929-1939. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 50, 1929-1939
Adams, H, van de Garde, E M W, Vugts, D J, Grutters, J C, Oyen, W J G & Keijsers, R G 2023, ' [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis : a phase 2 trial ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 7, pp. 1929-1939 . https://doi.org/10.1007/s00259-023-06143-1
European Journal of Nuclear Medicine and Molecular Imaging, 50(7), 1929-1939. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 50, 1929-1939
Introduction Immune-mediated interstitial pneumonitis may be treated with anti-CD20 therapy after failure of conventional therapies. However, clinical response is variable. It was hypothesized that autoreactive CD20-positive cells may play an importa
Autor:
M G Platenburg, C H Van Moorsel, I A Wiertz, P Zanen, J J Van Der Vis, A D Vorselaars, M Veltkamp, J C Grutters
Publikováno v:
12.01 - Idiopathic interstitial pneumonias.
Autor:
V Kahlmann, C C Moor, S J Van Helmondt, R L Mostard, M L Van Der Lee, J C Grutters, M S Wijsenbeek, M Veltkamp
Publikováno v:
12.03 - Sarcoidosis and other granulomatous ILD/DPLD.
Publikováno v:
12.03 - Sarcoidosis and other granulomatous ILD/DPLD.
Autor:
S Rebers, E Vermeulen, A P Brandenburg, T J Stoof, B Zupan-Kajcovski, W J W Bos, M J Jonker, C J Bax, W J van Driel, V J Verwaal, M W van den Brekel, J C Grutters, R A Tupker, L Plusjé, R de Bree, J H Schagen van Leeuwen, E G J Vermeulen, R A de Leeuw, R M Brohet, N K Aaronson, F E Van Leeuwen, M K Schmidt
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)
BACKGROUND:Despite much debate, there is little evidence on consequences of consent procedures for residual tissue use. Here, we investigated these consequences for the availability of residual tissue for medical research, clinical practice, and pati
Externí odkaz:
https://doaj.org/article/4064b89edb524ad9bfc2dc8c7187d3c3
Autor:
T. W. Hoffman, J. J. van der Vis, M. F. M. van Oosterhout, H. W. van Es, D. A. van Kessel, J. C. Grutters, C. H. M. van Moorsel
Publikováno v:
Case Reports in Pulmonology, Vol 2016 (2016)
Pulmonary fibrosis is a frequent manifestation of telomere syndromes. Telomere gene mutations are found in up to 25% and 3% of patients with familial disease and sporadic disease, respectively. The telomere gene TINF2 encodes an eponymous protein tha
Externí odkaz:
https://doaj.org/article/067f5a2eeeb44ab2a8442efe030ab1dd